In the last trading session, 3.13 million Aspen Aerogels Inc. (NYSE:ASPN) shares changed hands as the company’s beta touched 2.16. With the company’s per share price at $21.60 changed hands at -$0.84 or -3.74% during last session, the market valuation stood at $1.66B. ASPN’s last price was a discount, traded about -53.47% off its 52-week high of $33.15. The share price had its 52-week low at $6.62, which suggests the last value was 69.35% up since then. When we look at Aspen Aerogels Inc.’s average trading volume, we note the 10-day average is 3.23 million shares, with the 3-month average coming to 1.99 million.

Analysts gave the Aspen Aerogels Inc. (ASPN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.09. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ASPN as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Aspen Aerogels Inc.’s EPS for the current quarter is expected to be -0.04.

Aspen Aerogels Inc. (NYSE:ASPN) trade information

Instantly ASPN was in red as seen at the end of in last trading. With action -6.49%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 36.88%, with the 5-day performance at -6.49% in the red. However, in the 30-day time frame, Aspen Aerogels Inc. (NYSE:ASPN) is -24.90% down. Looking at the short shares, we see there were 6.48 million shares sold at short interest cover period of 3.89 days.

The consensus price target for the stock as assigned by Wall Street analysts is 32, meaning bulls need an upside of 32.5% from its current market value. According to analyst projections, ASPN’s forecast low is 18 with 38 as the target high. To hit the forecast high, the stock’s price needs a -75.93% plunge from its current level, while the stock would need to tank 16.67% for it to hit the projected low.

Aspen Aerogels Inc. (ASPN) estimates and forecasts

Data shows that the Aspen Aerogels Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 44.39% over the past 6 months, a 125.76% in annual growth rate that is considerably higher than the industry average of 7.50%. Year-over-year growth is forecast to reach 71.50% up from the last financial year.

Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 105.16M. 11 analysts are of the opinion that Aspen Aerogels Inc.’s revenue for the current quarter will be 91.96M. The company’s revenue for the corresponding quarters a year ago was 51.84M and 84.22M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 102.90%. The estimates for the next quarter sales put growth at 9.20%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 14.58%. The 2024 estimates are for Aspen Aerogels Inc. earnings to increase by 124.58%.

ASPN Dividends

Aspen Aerogels Inc. is expected to release its next quarterly earnings report in November.

Aspen Aerogels Inc. (NYSE:ASPN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 17.66% of Aspen Aerogels Inc. shares while 80.65% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 97.95%. There are 80.65% institutions holding the Aspen Aerogels Inc. stock share, with KIM, LLC the top institutional holder. As of 2024-06-30, the company held 16.209% of the shares, roughly 12.28 million ASPN shares worth $292.89 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 5.9295% or 4.49 million shares worth $107.14 million as of 2024-06-30.